Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

Abstract

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project

“…We revised the lecture materials associated with items for which knowledge was considered insufficient, and reported results suggesting that the revision of the lecture materials may have improved the degree of understanding of the clinical practice guidelines. 28 This study has several limitations that should be taken into account when interpreting the results. First, because this study was performed in a single-arm design without a control group, it was difficult to assess the precise effectiveness of the programme despite it being a before-and-after comparison study.…”

“…We revised the lecture materials associated with items for which knowledge was considered insufficient, and reported results suggesting that the revision of the lecture materials may have improved the degree of understanding of the clinical practice guidelines. 28…”

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

“…Written informed consent was obtained from all participants after the procedures had been fully explained by a chief researcher at the facility. [8][9][10][11][12][13][14][15][16] This study was approved by the ethics committees of the National Center of Neurology and Psychiatry (A2017-105) and each participating university/hospital/clinic. The study procedures were conducted according to the Declaration of Helsinki.…”

“…The EGUIDE project developed a 2-day educational course (1 day for each disorder) for psychiatrists to learn about the Japanese treatment guidelines for schizophrenia and MDD. [8][9][10][11][12][13][14][15][16] In addition, this study examined the effectiveness of the guideline education program by assessing participants' prescribing behaviors (prescribing at discharge for patients with moderate to severe schizophrenia or MDD). The EGUIDE study found antipsychotic polypharmacy for schizophrenia and antidepressant polypharmacy for MDD.…”

Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry

“…Major Depressive Disorder" by the Japanese Society of Mood Disorders 1 and "Guidelines for the Pharmacological Treatment of Schizophrenia" by the Japanese Society of Neuropsychopharmacology 2 . The project is original in that it evaluates multiple indicators and provides feedback on the lecture and development of CPGs 3 . As of June 2021, 243 medical institutions, including 44 universities, were participating in this project in Japan.…”